The ability to reduce body weight is consistently observed in individuals taking SGLT2 inhibitors, but this weight loss is moderate due to counter-regulatory mechanisms striving to maintain body weight
Patients with severe gastrointestinal disease (gastroparesis, inflammatory bowel disease) may have difficulty tolerating these medications
Yes, high demand has led to the emergence of unregulated companies and scammers producing substandard or counterfeit versions of these medications
Last reviewed June 26, 2026
Our commitment to quality means each vial undergoes rigorous third-party testing to confirm purity levels of 98%, accurate structural verification via mass spectrometry, thiol content validation, and stability assessment via HPLC
Accessibility and Personal Needs Sometimes the choice is driven by what is most accessible through a persons specific health program or pharmacy